Busulfan/Fludarabine phosphate/Tacrolimus/Methotrexate/G-CSF

( DrugBank: Busulfan, Fludarabine / KEGG DRUG: Busulfan, Fludarabine )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
60	再生不良性貧血	1

60. 再生不良性貧血

臨床試験数 : 245 / 薬物数 : 318 - (DrugBank : 86) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 166

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00516152 (ClinicalTrials.gov)	November 2002	13/8/2007	Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoiet ...	Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoiet ...	Chronic Myeloid Leukemia;Acute Myelogenous Leukemia;Myelodysplasia;Acute Lymphocytic Leukemia;Severe ...	Drug: Busulfan/Fludarabine phosphate/Tacrolimus/Methotrexate/G-CSF	University of California, San Francisco	NULL	Completed	15 Years	61 Years	Both	36	Phase 2	United States

First Previous1Next Last